Skip to main content
Signal8

Mantelli Flavio

SEC insider (Form 3/4/5 filer). CIK 0002127572. CHIEF MEDICAL OFFICER at OKYO Pharma Ltd (OKYO). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 21, 2026. Located in LONDON.

Companies Mantelli Flavio has filed insider reports for

  • OKYO Pharma Ltd (OKYO): Officer, CHIEF MEDICAL OFFICER
Mantelli Flavio profile photo

Mantelli Flavio

CIK: 0002127572

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OKYO Pharma Ltd logo
OKYO

OKYO Pharma Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • OKYO Pharma Ltd logo
    OKYO

    OKYO Pharma Ltd

    Jul 21, 2026
    Purchase
    Direct
    20K shares at avg. $1.40$28K
  • OKYO Pharma Ltd logo
    OKYO

    OKYO Pharma Ltd

    Jul 21, 2026
    Award
    Direct
    20K shares at avg. $1.40$28K

1-2 of 2